500
0
0

November is Lung Cancer Awareness Month. Explore both sides of lung cancer diagnosis →

Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
🔍
Folder: Who We Are
Back
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Folder: Reports
Back
Annual Reports
SCLC Report
Policy and resources
English
Back
Our Members
No results found
Policy and EU affairs Web Team 02/10/2026 Policy and EU affairs Web Team 02/10/2026

The EU Biotech Act: what it means for people living with lung cancer

Read More
Living with lung cancer Web Team 29/09/2026 Living with lung cancer Web Team 29/09/2026

Lung cancer and heart health: understanding the two-way connection

Read More
Living with lung cancer Web Team 24/09/2026 Living with lung cancer Web Team 24/09/2026

What is lung cancer patient navigation?

Lung cancer care can involve many tests, appointments, specialists and services. Patient navigation gives people a named source of support to help them understand and move through their care.

Read More
Prevention and risk Web Team 06/09/2026 Prevention and risk Web Team 06/09/2026

Microplastics and lung cancer: what does the latest evidence show?

Read More
Biomarkers and diagnosis Web Team 29/08/2026 Biomarkers and diagnosis Web Team 29/08/2026

ctDNA and ctRNA in lung cancer: what can liquid biopsy tell us?

Read More
Screening and early diagnosis Web Team 25/08/2026 Screening and early diagnosis Web Team 25/08/2026

Lung cancer screening in Europe: how do we make access fair?

Read More
Prevention and risk Web Team 16/08/2026 Prevention and risk Web Team 16/08/2026

Hotter Summers, Dirtier Air: Heatwaves and Lung Cancer in Europe

Read More
Biomarkers and diagnosis Web Team 07/08/2026 Biomarkers and diagnosis Web Team 07/08/2026

Lung cancer staging: is TNM still enough?

Read More
Biomarkers and diagnosis, Access to treatment Web Team 05/08/2026 Biomarkers and diagnosis, Access to treatment Web Team 05/08/2026

Biomarker testing is moving faster than ever. Is Europe keeping up?

Read More
Prevention and risk Web Team 28/07/2026 Prevention and risk Web Team 28/07/2026

Wildfire smoke and lung cancer: what does the evidence show?

Read More
Living with lung cancer Web Team 24/07/2026 Living with lung cancer Web Team 24/07/2026

Why People with Lung Cancer Face a Higher Risk of Hospital Infections

Read More
Treatment and research, Biomarkers and diagnosis Web Team 17/07/2026 Treatment and research, Biomarkers and diagnosis Web Team 17/07/2026

TROP2 and lung cancer: what we know so far

Read More
Screening and early diagnosis Web Team 14/07/2026 Screening and early diagnosis Web Team 14/07/2026

How Doctors Find and Remove Tiny Lung Nodules

Read More
Treatment and research Web Team 10/07/2026 Treatment and research Web Team 10/07/2026

New Treatments for Small Cell Lung Cancer in Europe

Read More
Treatment and research Web Team 07/07/2026 Treatment and research Web Team 07/07/2026

CAR T Cells and Lung Cancer: Could This Immunotherapy Become a Future Treatment?

Read More
Living with lung cancer Web Team 05/07/2026 Living with lung cancer Web Team 05/07/2026

Patient-reported outcomes: asking people with lung cancer how they are

Read More
Treatment and research Web Team 04/07/2026 Treatment and research Web Team 04/07/2026

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

Read More
Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026

What the EU Critical Medicines Act means for lung cancer

Read More
Prevention and risk Web Team 22/06/2026 Prevention and risk Web Team 22/06/2026

Early-onset lung cancer: why are more younger adults being diagnosed?

Read More
Prevention and risk Web Team 13/06/2026 Prevention and risk Web Team 13/06/2026

Lung cancer in people who have never smoked: what the evidence now shows

Read More
Older Posts

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on the 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY
COMPLIANCE

© Lung Cancer Europe 2026 | Designed by Laura Jones